PureTech Health plc (NASDAQ:PRTC – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $26.15, but opened at $27.33. PureTech Health shares last traded at $27.48, with a volume of 308 shares changing hands.
PureTech Health Stock Performance
The firm’s 50 day moving average is $26.44 and its 200 day moving average is $23.59.
PureTech Health Company Profile
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- What Is WallStreetBets and What Stocks Are They Targeting?
- High-Yield Texas Instruments Could Hit New Highs Soon
- Dividend Payout Ratio Calculator
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to invest in marijuana stocks in 7 steps
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.